Preventing first stroke in people with high-risk blood pressure
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a study medicine regimen can help prevent a first stroke in people with hard-to-control “high homocysteine” risk factors linked to a specific gene type. You may qualify if you have certain blood pressure levels, a specific MTHFR gene result, and related blood test findings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 45 and under 75 years old
- You have primary (not secondary) high blood pressure—either on meds recently or high readings at two doctor visits
- Your genetic test shows MTHFR 677 is CC or CT
- Your blood tests show high homocysteine (at least 10) and low folate (below 12)
- You’re able and willing to sign consent and follow the study plan
- You have not had a stroke or major heart/blocked-artery event during the study’s early “run-in” period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an approach to prevent first-time stroke and heart problems in people with high blood pressure who also have a specific genetic test result (MTHFR 677 TT). It may help by lowering risk before a first stroke happens.
This study tests whether combining folic acid supplements with intensive blood pressure treatment can help people who have had a small stroke or have certain brain changes seen on MRI. It may slow down further damage to the brain's small blood vessels.
This trial tests a new medication, AZD0780, to see if it helps prevent major cardiovascular events like heart attacks or strokes in people who already have heart or blood vessel disease, or are at high risk for a first event. It might be a good fit if your cholesterol isn't well-controlled despite current treatments.
This trial tests a new medication to prevent strokes and blood clots in people with atrial fibrillation (an irregular heartbeat) who cannot safely take standard blood thinners. The drug works by blocking a different clotting factor, which may lower bleeding risks.
This trial tests whether taking a blood thinner can lower the risk of stroke in people who had atrial fibrillation (an irregular heartbeat) that happened temporarily around a stressful illness or surgery. It looks especially at people at higher risk for stroke after that episode.
This study looks at a substance in your blood called homocysteine and how it affects the early filling of your heart's main pumping chamber. It may help doctors understand heart risks in people newly diagnosed with high blood pressure.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.